News Nevada State Board of Pharmacy
... most likely will be many times the human dose based on weight. Thyroid hormone is also dosed much higher in dogs than in humans. Antihistamines are often prescribed for dogs with allergies and the pet owner must be made aware that many preparations contain a decongestant like pseudoephedrine as well ...
... most likely will be many times the human dose based on weight. Thyroid hormone is also dosed much higher in dogs than in humans. Antihistamines are often prescribed for dogs with allergies and the pet owner must be made aware that many preparations contain a decongestant like pseudoephedrine as well ...
Becoming Neurochemical Selves
... with the discovery of its psychiatric effects. It was taken by RhônePoulenc to Canada, and licensed to Smith Kline and French who promoted it heavily in the United States under the name of Thorazine where it spread rapidly through the crowded psychiatric hospitals making them $75m in 1955 alone. It ...
... with the discovery of its psychiatric effects. It was taken by RhônePoulenc to Canada, and licensed to Smith Kline and French who promoted it heavily in the United States under the name of Thorazine where it spread rapidly through the crowded psychiatric hospitals making them $75m in 1955 alone. It ...
Drug Development Pipeline
... Gene-based and cellular biologics, for example, often are at the forefront of biomedical research, and may be used to treat a variety of medical conditions for which no other treatments are available. ...
... Gene-based and cellular biologics, for example, often are at the forefront of biomedical research, and may be used to treat a variety of medical conditions for which no other treatments are available. ...
How to do an enquiry on interactions between complementary or
... Complementary and/or alternative medicines (CAMs) are increasingly being used by members of the public to treat common ailments. Medicines Information centres may be asked by members of the public or other healthcare professionals about the potential use of CAMs in combination with a patient’s conve ...
... Complementary and/or alternative medicines (CAMs) are increasingly being used by members of the public to treat common ailments. Medicines Information centres may be asked by members of the public or other healthcare professionals about the potential use of CAMs in combination with a patient’s conve ...
Opiate Abuse 2011
... In 2008, the last year for which numbers are available, 505 people in the state died from prescription drug overdoses and 646 people were hospitalized. Stevens, Clallam, Spokane, Grant and Snohomish counties led the way in 2008 death rates from prescription medications. In Stevens County, the rate w ...
... In 2008, the last year for which numbers are available, 505 people in the state died from prescription drug overdoses and 646 people were hospitalized. Stevens, Clallam, Spokane, Grant and Snohomish counties led the way in 2008 death rates from prescription medications. In Stevens County, the rate w ...
Formulation, Development and Characterization of Emulgel of
... spreading coefficient and necessitate to apply with rubbing. They also show evidence of the problem of stability. Due to all these factors, within the major group of semisolid preparations, the use of transparent gels has increased both in cosmetics and in pharmaceutical preparations [1-2]. A gel is ...
... spreading coefficient and necessitate to apply with rubbing. They also show evidence of the problem of stability. Due to all these factors, within the major group of semisolid preparations, the use of transparent gels has increased both in cosmetics and in pharmaceutical preparations [1-2]. A gel is ...
Slide 1
... “runny nose” during meals on a daily basis. He asks if there is a medication to stop his runny nose. Although inconvenient at mealtime, he is ...
... “runny nose” during meals on a daily basis. He asks if there is a medication to stop his runny nose. Although inconvenient at mealtime, he is ...
TURKU – FINLAND and OSAKA - JAPAN Press release on February
... (“Maruishi”) announced today that they have signed a License Agreement which grants Maruishi the exclusive license for the development and commercialization of the Traumakine-program in Japan. This agreement is subsequent to the Letter of Intent which was concluded on December 28th 2010 and the fina ...
... (“Maruishi”) announced today that they have signed a License Agreement which grants Maruishi the exclusive license for the development and commercialization of the Traumakine-program in Japan. This agreement is subsequent to the Letter of Intent which was concluded on December 28th 2010 and the fina ...
Downers: A New Look at Depressant Drugs
... quickly — so fast, in fact, that users must take increasingly-large doses and face increasingly-serious risks. ■ Lethality. Barbiturates act on all areas of the central nervous system, including areas of the brain that regulate respiration, raising the risk of fatal overdose. ■ Side effects. Barbitu ...
... quickly — so fast, in fact, that users must take increasingly-large doses and face increasingly-serious risks. ■ Lethality. Barbiturates act on all areas of the central nervous system, including areas of the brain that regulate respiration, raising the risk of fatal overdose. ■ Side effects. Barbitu ...
Legislative Advocacy: The Safety of Over-the
... Products containing active ingredients or indications not in the monograph require an approved “New Drug Application” ...
... Products containing active ingredients or indications not in the monograph require an approved “New Drug Application” ...
May - Indian Pharmaceutical Association
... which are engaged in chemical and biotechnology-based research of new medicines. The trend in patent applications is a pointer to India's growing stature, wherein Indian companies that were once cautious have proved themselves well versed in the game of innovation. For an average drug, every day of ...
... which are engaged in chemical and biotechnology-based research of new medicines. The trend in patent applications is a pointer to India's growing stature, wherein Indian companies that were once cautious have proved themselves well versed in the game of innovation. For an average drug, every day of ...
Redesign of a clinical decision support system for a drug - drug interaction alert
... particular have the potential to reduce and prevent morbidity and mortality associated with adverse events and improve the quality of patient care (2). Most electronic health records (EHR) has CDSS used as support for clinical decision making. In the context of electronic prescribing systems, knowle ...
... particular have the potential to reduce and prevent morbidity and mortality associated with adverse events and improve the quality of patient care (2). Most electronic health records (EHR) has CDSS used as support for clinical decision making. In the context of electronic prescribing systems, knowle ...
Dr. Mary Teeling Dept. of Pharmacology & Therapeutics / Centre for
... • Increased rate of “spontaneous” disease in specific populations – increased rate of vaginal cancers in daughters of women who received stilboestrol during pregnancy – 20 year time lapse **Not predictable, often hard to detect but pharmacovigilance may pick them up eventually** ...
... • Increased rate of “spontaneous” disease in specific populations – increased rate of vaginal cancers in daughters of women who received stilboestrol during pregnancy – 20 year time lapse **Not predictable, often hard to detect but pharmacovigilance may pick them up eventually** ...
PDF - Santen Inc.
... ophthalmic solution) 0.1%. Santen continues its responsibility for manufacturing, clinical and regulatory activities associated with all four of the products. “Santen has world-class R&D and clinical development capabilities,” says Santen Inc.’s President and CEO Adrienne Graves, PhD. “IQUIX is an i ...
... ophthalmic solution) 0.1%. Santen continues its responsibility for manufacturing, clinical and regulatory activities associated with all four of the products. “Santen has world-class R&D and clinical development capabilities,” says Santen Inc.’s President and CEO Adrienne Graves, PhD. “IQUIX is an i ...
Blister Packaging of Oral Solids - Challenges for the Pharma
... patients. Achieving better treatment outcomes has an impact on society as a whole: patients and their families live longer together and enjoy a better quality of life; social systems can plan for lower costs for acute care and assisted living; employers benefit from lower absenteeism rates; and phys ...
... patients. Achieving better treatment outcomes has an impact on society as a whole: patients and their families live longer together and enjoy a better quality of life; social systems can plan for lower costs for acute care and assisted living; employers benefit from lower absenteeism rates; and phys ...
Spinout Equinox Pharma speeds up and reduces the cost of drug
... in a matter of hours – with important implications for speeding up drug discovery. Equinox is following a mixed-business model of ‘fee-forservice’ and in-house drug discovery. Currently, Equinox is applying its technology to develop novel antibiotics. In addition, INDDEx has been used at Imperial Co ...
... in a matter of hours – with important implications for speeding up drug discovery. Equinox is following a mixed-business model of ‘fee-forservice’ and in-house drug discovery. Currently, Equinox is applying its technology to develop novel antibiotics. In addition, INDDEx has been used at Imperial Co ...
Inhalation Drug Delivery ‐
... the number of labeled doses. Once the number of required doses is determined, the quality control test will evaluate up to the labeled number of actuations, typically measuring dose content uniformity of 10 actuations spread over beginning, middle and end. Process Development Following init ...
... the number of labeled doses. Once the number of required doses is determined, the quality control test will evaluate up to the labeled number of actuations, typically measuring dose content uniformity of 10 actuations spread over beginning, middle and end. Process Development Following init ...
Substitution treatment Methadone 2 stage Engl
... 3.5. The objectives of the treatment From a physician point of view, the most important objective is to "maintain contact with the system of assistance ", followed by "the improvement of the self-image ". The objective of abstinence is of little importance for the physicians working in Brussels’s i ...
... 3.5. The objectives of the treatment From a physician point of view, the most important objective is to "maintain contact with the system of assistance ", followed by "the improvement of the self-image ". The objective of abstinence is of little importance for the physicians working in Brussels’s i ...
Why People Abuse Prescription Drugs “The Psychopharmacology of Addiction”
... PARTICULAR DRUGS AND MEDICATIONS THAT POSSESS A POTENTIAL FOR PSYCHOLOGICAL AND/OR PHYSICAL ABUSE AND DEPENDENCE INTO FIVE (5) ...
... PARTICULAR DRUGS AND MEDICATIONS THAT POSSESS A POTENTIAL FOR PSYCHOLOGICAL AND/OR PHYSICAL ABUSE AND DEPENDENCE INTO FIVE (5) ...
Wholesaler Taskforce
... Substitution of less toxic chemicals usually not possible Lack of application of EPA regulations to finished dosage forms No readily retrievable source of information on specific products Lack of knowledge of environmental regulations and the need to comply ...
... Substitution of less toxic chemicals usually not possible Lack of application of EPA regulations to finished dosage forms No readily retrievable source of information on specific products Lack of knowledge of environmental regulations and the need to comply ...
Psychoactive drugs - Stamford High School
... cause irreversible health damage. Certain drugs are classified by their effects. They may speed up or slow down the senses, or affect judgment. ...
... cause irreversible health damage. Certain drugs are classified by their effects. They may speed up or slow down the senses, or affect judgment. ...